Incidence of 'low-risk but not no-risk' features of cancer prior to high-risk feature occurrence: An observational cohort study in primary care.
dc.contributor.author | Moore, SF | |
dc.contributor.author | Price, SJ | |
dc.contributor.author | Bostock, J | |
dc.contributor.author | Neal, RD | |
dc.contributor.author | Hamilton, W | |
dc.date.accessioned | 2023-08-23T08:33:24Z | |
dc.date.issued | 2023-08-02 | |
dc.date.updated | 2023-08-22T15:41:29Z | |
dc.description.abstract | Diagnosing cancer may be expedited by decreasing referral risk threshold. Clinical Practice Research Datalink participants (≥40 years) had a positive predictive value (PPV) ≥3% feature for breast, lung, colorectal, oesophagogastric, pancreatic, renal, bladder, prostatic, ovarian, endometrial or laryngeal cancer in 2016. The numbers of participants with features representing a 1-1.99% or 2-2.99% PPV for same cancer in the previous year were reported, alongside the time difference between meeting the ≥3% criteria and the lower threshold criteria. A total of 8616 participants had a PPV ≥3% feature, of whom 365 (4.2%) and 1147 (13.3%), respectively, met 2-2.99% and 1-1.99% criteria in the preceding year. The median time difference was 131 days (Interquartile Range (IQR) 27 to 256) for the 2-2.99% band and 179 days (IQR 58 to 289) for the 1-1.99% band. Results were heterogeneous across cancer sites. For some cancers, participants may progress from presenting lower- to higher-risk features before meeting urgent referral criteria; however, this was not usually the case. The details of specific features across multiple cancer sites will allow for a tailored approach to future reductions in referral thresholds, potentially improving the efficiency of urgent cancer referrals for the benefit both of individuals and the National Health Service (NHS). | en_GB |
dc.description.sponsorship | National Institute for Health Research | en_GB |
dc.description.sponsorship | National Institute for Health Research | en_GB |
dc.format.extent | 3936- | |
dc.format.medium | Electronic | |
dc.identifier.citation | Vol. 15, No. 15, article 3936 | en_GB |
dc.identifier.doi | https://doi.org/10.3390/cancers15153936 | |
dc.identifier.grantnumber | Career Progression Fellowship, C021 | en_GB |
dc.identifier.grantnumber | PR-PRU-1217-21601 | en_GB |
dc.identifier.uri | http://hdl.handle.net/10871/133844 | |
dc.identifier | ORCID: 0000-0001-9815-5665 (Moore, Sarah F) | |
dc.identifier | ScopusID: 55932774300 (Moore, Sarah F) | |
dc.identifier | ORCID: 0000-0002-2228-2374 (Price, Sarah J) | |
dc.identifier | ScopusID: 57195915869 (Price, Sarah J) | |
dc.identifier | ResearcherID: D-2641-2016 (Price, Sarah J) | |
dc.identifier | ORCID: 0000-0002-3544-2744 (Neal, Richard D) | |
dc.identifier | ScopusID: 57153542700 | 57209487273 (Neal, Richard D) | |
dc.identifier | ORCID: 0000-0003-1611-1373 (Hamilton, Willie) | |
dc.identifier | ScopusID: 55031252700 | 57209301809 | 58001147600 (Hamilton, Willie) | |
dc.identifier | ResearcherID: G-8612-2014 (Hamilton, Willie) | |
dc.language.iso | en | en_GB |
dc.publisher | MDPI | en_GB |
dc.relation.url | https://www.ncbi.nlm.nih.gov/pubmed/37568751 | en_GB |
dc.rights | © 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). | en_GB |
dc.subject | cancer | en_GB |
dc.subject | early diagnosis | en_GB |
dc.subject | primary care | en_GB |
dc.subject | referrals | en_GB |
dc.title | Incidence of 'low-risk but not no-risk' features of cancer prior to high-risk feature occurrence: An observational cohort study in primary care. | en_GB |
dc.type | Article | en_GB |
dc.date.available | 2023-08-23T08:33:24Z | |
dc.identifier.issn | 2072-6694 | |
exeter.place-of-publication | Switzerland | |
dc.description | This is the final version. Available from MDPI via the DOI in this record. | en_GB |
dc.description | Data Availability Statement: The anonymised participant data from this study are not available, in line with the CPRD’s data security policy. CPRD code libraries are available from the authors on request. | en_GB |
dc.identifier.journal | Cancers | en_GB |
dc.relation.ispartof | Cancers (Basel), 15(15) | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | en_GB |
dcterms.dateAccepted | 2023-07-27 | |
rioxxterms.version | VoR | en_GB |
rioxxterms.licenseref.startdate | 2023-08-02 | |
rioxxterms.type | Journal Article/Review | en_GB |
refterms.dateFCD | 2023-08-23T08:29:38Z | |
refterms.versionFCD | VoR | |
refterms.dateFOA | 2023-08-23T08:33:25Z | |
refterms.panel | A | en_GB |
refterms.dateFirstOnline | 2023-08-02 |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's licence is described as © 2023 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).